Charles Elliott Sigal Vir Biotechnology, Inc. (VIR) insider trading activity

Charles Elliott Sigal is Director of Vir Biotechnology, Inc.. Currently has a direct ownership of 31,806 shares of VIR, which is worth approximately $163,800. The most recent transaction as insider was on May 30, 2025, when has been sold 8,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.8K

33.6% 3M change

33.6% 12M change

Total Value Held $163,800

Charles Elliott Sigal Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 30 2025	BUY Grant, award, or other acquisition	-	8,000 Added 20.1%	31,806 Common Stock
May 30 2024	BUY Grant, award, or other acquisition	-	8,000 Added 25.15%	23,806 Common Stock
May 22 2023	BUY Grant, award, or other acquisition	-	6,027 Added 27.61%	15,806 Common Stock
May 23 2022	BUY Grant, award, or other acquisition	-	6,405 Added 39.58%	9,779 Common Stock
May 21 2021	BUY Grant, award, or other acquisition	-	3,374 Added 50.0%	3,374 Common Stock

Also insider at

SURF

Surface Oncology, Inc. Healthcare

Director

ADAP

Adaptimmune Therapeutics PLC Healthcare

Director

ALNY

ALNYLAM PHARMACEUTICALS, INC. Healthcare

Director

CES